Sierra Leone’s COVID-19 vaccination program, using community mobilization in remote villages, dramatically increased vaccine uptake, showing a scalable, cost-effective model for improving global vaccine access.
Despite Phase 3 win, Roche says rare autoimmune drug didn’t meet expectations
Roche’s Chugai Pharmaceutical said its immune disease drug Enspryng didn’t produce the results it was hoping for in a Phase 3 study in generalized myasthenia